1. Molecular Profile of Intrahepatic Cholangiocarcinoma
    Wellington Andraus et al, 2023, International Journal of Molecular Sciences CrossRef
  2. Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer
    Jia Liu et al, 2017, Oncotarget CrossRef
  3. Analytical Challenges in Development of Chemoresistance Predictors for Precision Oncology
    Mariana Bleker de Oliveira et al, 2020, Analytical Chemistry CrossRef
  4. ERCC1 expression and platinum chemosensitivity in patients with ovarian cancer: A meta-analysis
    Chunjie Zhang et al, 2020, The International Journal of Biological Markers CrossRef
  5. Elevated PAF1-RAD52 axis confers chemoresistance to human cancers
    Sanchita Rauth et al, 2023, Cell Reports CrossRef
  6. Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer
    James Scurry et al, 2018, Gynecologic Oncology CrossRef
  7. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors
    Shahil Alam et al, 2024, Cancer Drug Resistance CrossRef
  8. Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis
    Xueyong Liu et al, 2017, Oncotarget CrossRef
  9. Role of Nucleotide Excision Repair in Cisplatin Resistance
    Mingrui Duan et al, 2020, International Journal of Molecular Sciences CrossRef
  10. EXPRESSION LEVEL OF DRUG RESISTANCE GENES IN THE TUMOR OF OVARIAN CANCER PATIENTS AFTER NEOADJUVANT CHEMOTHERAPY
    L.V. Poludnyakova et al, 2019, Ulyanovsk Medico-biological Journal CrossRef
  11. Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach
    Samuele Lodovichi et al, 2020, International Journal of Molecular Sciences CrossRef
  12. Prognostic values of excision repair cross-complementing genes mRNA expression in ovarian cancer patients
    Menghuang Zhao et al, 2018, Life Sciences CrossRef
  13. ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers
    Tarek M. A. Abdel-Fatah et al, 2019, Cancers CrossRef
  14. A systematic literature review assessing if genetic biomarkers are predictors for platinum-based chemotherapy response in ovarian cancer patients
    Caitlin Phillips-Chavez et al, 2020, European Journal of Clinical Pharmacology CrossRef
  15. Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
    Reem Ali et al, 2022, International Journal of Molecular Sciences CrossRef